These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluation of the immunogenicity and efficacy of a chimeric OMP25-OMP31 antigen in BALB/c mice. Mohammadi Y. Vet Med Sci; 2021 Sep; 7(5):2008-2014. PubMed ID: 34057317 [Abstract] [Full Text] [Related]
6. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization. Abkar M, Lotfi AS, Amani J, Eskandari K, Ramandi MF, Salimian J, Brujeni GN, Alamian S, Kamali M, Koushki H. Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469 [Abstract] [Full Text] [Related]
9. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen. Golshani M, Rafati S, Siadat SD, Nejati-Moheimani M, Shahcheraghi F, Arsang A, Bouzari S. Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974 [Abstract] [Full Text] [Related]
11. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ. Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155 [Abstract] [Full Text] [Related]